Loading...
Indivior PLC
IZQVF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$20.97
$0.00(0.00%)
Indivior PLC (IZQVF) Financial Performance & Statements
Review Indivior PLC’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
8.69%
↑ 8.69%
Operating Income Growth
900.00%
↑ 900.00%
Net Income Growth
1150.00%
↑ 1150.00%
Operating Cash Flow Growth
111.43%
↑ 111.43%
Operating Margin
17.16%
↑ 17.16%
Gross Margin
78.47%
↑ 78.47%
Net Profit Margin
0.24%
↑ 0.24%
ROE
-1.21%
↓ 1.21%
ROIC
54.34%
↑ 54.34%
Indivior PLC (IZQVF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Indivior PLC stock.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $307.00M | $299.61M | $282.74M | $300.65M |
| Cost of Revenue | $69.00M | $116.24M | $52.76M | $55.41M |
| Gross Profit | $238.00M | $183.37M | $229.97M | $245.24M |
| Gross Profit Ratio | $0.78 | $0.61 | $0.81 | $0.82 |
| R&D Expenses | $22.63M | $27.05M | $27.88M | $30.78M |
| SG&A Expenses | $208.00M | $121.25M | $135.39M | $152.89M |
| Operating Expenses | $234.00M | $148.30M | $163.27M | $183.67M |
| Total Costs & Expenses | $303.00M | $264.54M | $216.03M | $239.08M |
| Interest Income | $5.00M | $6.00M | $6.00M | $10.00M |
| Interest Expense | $10.00M | $9.00M | $8.00M | $8.00M |
| Depreciation & Amortization | -$10.00M | $25.05M | $8.96M | $9.23M |
| EBITDA | $9.00M | -$101.21M | $80.64M | $70.80M |
| EBITDA Ratio | $0.03 | $0.20 | $0.27 | $0.24 |
| Operating Income | $4.00M | $35.07M | $66.70M | $61.57M |
| Operating Income Ratio | $0.01 | $0.12 | $0.24 | $0.20 |
| Other Income/Expenses (Net) | -$5.00M | -$3.00M | -$2.00M | $1.59M |
| Income Before Tax | -$1.00M | -$135.27M | $62.72M | $62.59M |
| Income Before Tax Ratio | -$0.003 | -$0.45 | $0.22 | $0.21 |
| Income Tax Expense | -$5.00M | -$28.06M | $15.93M | $7.18M |
| Net Income | $4.00M | -$107.22M | $47.00M | $54.00M |
| Net Income Ratio | $0.01 | -$0.36 | $0.17 | $0.18 |
| EPS | $0.03 | -$0.80 | $0.34 | $0.40 |
| Diluted EPS | $0.03 | -$0.80 | $0.34 | $0.39 |
| Weighted Avg Shares Outstanding | $132.10M | $134.85M | $135.74M | $137.32M |
| Weighted Avg Shares Outstanding (Diluted) | $133.55M | $134.85M | $138.71M | $141.95M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan